McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA.
Biomaterials. 2011 Apr;32(12):3233-43. doi: 10.1016/j.biomaterials.2011.01.057. Epub 2011 Feb 5.
Biologic scaffold materials composed of extracellular matrix (ECM) are typically derived by processes that involve decellularization of tissues or organs. Preservation of the complex composition and three-dimensional ultrastructure of the ECM is highly desirable but it is recognized that all methods of decellularization result in disruption of the architecture and potential loss of surface structure and composition. Physical methods and chemical and biologic agents are used in combination to lyse cells, followed by rinsing to remove cell remnants. Effective decellularization methodology is dictated by factors such as tissue density and organization, geometric and biologic properties desired for the end product, and the targeted clinical application. Tissue decellularization with preservation of ECM integrity and bioactivity can be optimized by making educated decisions regarding the agents and techniques utilized during processing. An overview of decellularization methods, their effect upon resulting ECM structure and composition, and recently described perfusion techniques for whole organ decellularization techniques are presented herein.
生物支架材料由细胞外基质 (ECM) 组成,通常通过涉及组织或器官脱细胞化的过程来获得。高度期望保留 ECM 的复杂组成和三维超微结构,但人们认识到,所有脱细胞化方法都会破坏架构,并可能导致表面结构和组成的损失。物理方法以及化学和生物试剂被联合用于裂解细胞,然后冲洗以去除细胞残留物。有效的脱细胞化方法学取决于组织密度和组织、最终产品所需的几何和生物学特性以及目标临床应用等因素。通过明智地决策在处理过程中使用的试剂和技术,可以优化保留 ECM 完整性和生物活性的组织脱细胞化。本文介绍了脱细胞化方法及其对最终 ECM 结构和组成的影响,以及最近描述的用于整个器官脱细胞化技术的灌注技术。